Replies to post #5873 on GTC Biotherapeutics (fka GTCB)

[ThomasS]

IMO, A US FDA approval would go miles towards that end; it signals that transgenics is here to stay. Once folks realize the vast potential after that milestone, it should be off to the races. The PII DIC data will come in shortly after the FDA milestone and shall cement the potential for the ignorant out there on Wall Street.
Many are still wary of transgenics; (we almost didn't get EU approval; USA is still the benchmark) further, most have never heard of GTC.

[jessellivermore]

No one knows.....

IMHO If I understand whats happening, Transgenics (later GTCB) burned some fund managers and analysts. They are like Homer Simpson's view of God,, very powerful, but insecure.

IMHO If GTCB was a new company without the 2000 AT3 FDA fiasco and the EMEA problem, they would be trading much higher. Considering the value of their IP, the stategic importance of their production platform and the sex appeal of the concept; I would guess easily above twenty. When I mention the ring of the cash register I mean they need to make money, and they will. The possibility of this company failing is as low as I have ever seen for a fledgling BT. The worse thing that could happen is the company could be bought out for a price far too low.

The speed of light does not need the defense of opinions.